FDA shakes up weight loss market as Mounjaro shortage ends
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
FierceBiotech15d
FDA approves Exact Sciences’ next-gen Cologuard Plus home screening test
Ten years after first collecting an FDA approval, it’s time for version ... obtaining a nod from the FDA in August 2014. The company plans to deliver Cologuard Plus through the same commercial ...
Investopedia16d
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
Bloomberg / Contributor / Getty Images Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list ...
The Washington Post17d
Eli Lilly’s weight-loss drug no longer in shortage, FDA says
A previous version of this article incorrectly stated that federal regulators inspect imitation weight-loss drugs made by compounding pharmacies. The regulators inspect pharmacy operations but do ...
Fast Company17d
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
unless the approved drug is on the FDA’s drug shortage list. However, Hims’ weight-loss injection does not use tirzepatide. Its injection is a compounded form of semaglutide, the medicine sold ...
Daily Reporter17d
Eli Lilly’s weight-loss drugs no longer in shortage, FDA says
Zepbound also has been in short supply since being approved less than a year ago as demand for weight-loss drugs has skyrocketed. The FDA’s shortage designation had let compounding pharmacies ...
Investing18d
Mainz Biomed plans FDA trial for cancer test in 2025
This could reflect investor optimism about the company's strategic plans and potential FDA approval. For investors seeking a more comprehensive analysis, InvestingPro offers 7 additional tips for ...
USA Today22d
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment option for the first time in more than three decades, after the Food and Drug Administration Thursday approved a new kind of drug. Studies ...
Fox News22d
New schizophrenia drug gets FDA approval, taking novel approach to treating brain disorder
A new drug has been approved for the treatment of schizophrenia in adults. On Thursday, the U.S. Food and Drug Administration (FDA) approved COBENFY (xanomeline and trospium chloride), an oral ...
Indiatimes22d
Bristol Myers gets FDA approval for Cobenfy to treat Schizophrenia
The US FDA has approved Bristol Myers ... beginning with today’s approval for schizophrenia.” Bristol Myers Squibb plans to make Cobenfy, a twice-daily pill, available by late October.
Reason22d
In a Victory for the Free Market, FDA Approves New Schizophrenia Drug
The U.S. Food and Drug Administration (FDA) approved a novel antipsychotic schizophrenia drug late Thursday, marking the first new treatment in decades for the mental health condition that affects ...
Business Standard22d
US FDA approves Bristol Myers' Squibb drug for treating schizophrenia
The US FDA approved Bristol Myers Squibb's schizophrenia drug on Thursday ... of the drug's patient population to be covered under Medicare and Medicaid insurance plans in the 12 to 18 months of its ...